New Century Pharmaceuticals

New Century Pharmaceuticals is a biotechnology company headquartered in Huntsville, Alabama, that focuses on the development of innovative drug delivery technologies. The company specializes in leveraging the properties of human serum albumin (HSA) to enhance the delivery, stability, and half-life of various therapeutic agents. Their approach utilizes protein engineering and structural biology to create next-generation treatments for oncology, infectious diseases, and inflammatory conditions. New Century Pharmaceuticals has a history of collaboration with NASA, utilizing microgravity environments to study protein crystallization to refine their drug designs. The company's platform aims to improve the therapeutic index of both small molecules and biologics by optimizing their binding to albumin.